bioAffinity Technologies, Inc. (BIAF) earnings
Quarterly results of bioAffinity Technologies, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) bioAffinity Technologies, Inc. reported revenue of $1.5M (+19% on the same quarter a year earlier) and a net loss of $3.4M.
Diluted earnings per share were -$0.64.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $1.5M | +19% | -$3.4M | -$0.64 |
| Q1 FY2026 | $1.4M | -27.1% | -$3.6M | -$0.81 |
| Q4 FY2025 | $1.6M | -27.8% | -$3.1M | - |
| Q3 FY2025 | $1.4M | -38.5% | -$5.1M | -$4.74 |
| Q2 FY2025 | $1.3M | - | -$4.1M | -$5.07 |
| Q1 FY2025 | $1.9M | - | -$2.7M | -$4.80 |
| Q4 FY2024 | $2.2M | - | -$3M | - |
| Q3 FY2024 | $2.4M | - | -$2M | -$4.84 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
What were bioAffinity Technologies, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, bioAffinity Technologies, Inc. reported revenue of $1.5M and a net loss of $3.4M. The figures come from its filing with the SEC.
Is bioAffinity Technologies, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $1.5M, up 19% from $1.3M in the same quarter a year earlier.
Get an email when BIAF reports
Follow BIAF and we email you its next results the day they are filed, with the numbers explained.